APA (7th ed.) Citation

C, X., JB, W., W, H., M, H., CK, R., JW, V., . . . T, W. (2026). Endogenous Glucagon-Like Peptide 1 Enhanced by Vildagliptin Reduces Triglyceride Appearance During Intraduodenal Fat Infusion in Type 2 Diabetes. Diabetes, 75(4), 630. https://doi.org/10.2337/db25-0980

Chicago Style (17th ed.) Citation

C, Xie, White JB, Huang W, Horowitz M, Rayner CK, Verjans JW, Snel MF, Psaltis PJ, and Wu T. "Endogenous Glucagon-Like Peptide 1 Enhanced by Vildagliptin Reduces Triglyceride Appearance During Intraduodenal Fat Infusion in Type 2 Diabetes." Diabetes 75, no. 4 (2026): 630. https://doi.org/10.2337/db25-0980.

MLA (9th ed.) Citation

C, Xie, et al. "Endogenous Glucagon-Like Peptide 1 Enhanced by Vildagliptin Reduces Triglyceride Appearance During Intraduodenal Fat Infusion in Type 2 Diabetes." Diabetes, vol. 75, no. 4, 2026, p. 630, https://doi.org/10.2337/db25-0980.